EP3322823A4 - Procédé de diagnostic, de pronostic et de suivi d'un cancer du sein et réactifs correspondants - Google Patents
Procédé de diagnostic, de pronostic et de suivi d'un cancer du sein et réactifs correspondants Download PDFInfo
- Publication number
- EP3322823A4 EP3322823A4 EP16823558.8A EP16823558A EP3322823A4 EP 3322823 A4 EP3322823 A4 EP 3322823A4 EP 16823558 A EP16823558 A EP 16823558A EP 3322823 A4 EP3322823 A4 EP 3322823A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- prognosis
- diagnosis
- monitoring
- methods
- breast cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562192540P | 2015-07-14 | 2015-07-14 | |
PCT/AU2016/050615 WO2017008117A1 (fr) | 2015-07-14 | 2016-07-14 | Procédé de diagnostic, de pronostic et de suivi d'un cancer du sein et réactifs correspondants |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3322823A1 EP3322823A1 (fr) | 2018-05-23 |
EP3322823A4 true EP3322823A4 (fr) | 2019-06-19 |
Family
ID=57756617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16823558.8A Withdrawn EP3322823A4 (fr) | 2015-07-14 | 2016-07-14 | Procédé de diagnostic, de pronostic et de suivi d'un cancer du sein et réactifs correspondants |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3322823A4 (fr) |
CN (1) | CN107922977A (fr) |
AU (1) | AU2016293381A1 (fr) |
WO (1) | WO2017008117A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108676879A (zh) * | 2018-05-24 | 2018-10-19 | 中国科学院北京基因组研究所 | 特异甲基化位点作为乳腺癌分子分型诊断标志物的应用 |
WO2020252721A1 (fr) * | 2019-06-20 | 2020-12-24 | The Johns Hopkins University | Marqueurs de méthylation de l'adn et leur utilisation dans la différenciation d'échantillons de biopsie de ganglions lymphatiques cancéreux suspectés |
WO2021174262A1 (fr) * | 2020-02-28 | 2021-09-02 | Loma Linda University | Méthodes d'évaluation de pronostic du cancer du sein et régimes de traitement basés sur l'état de méthylation de la région ins-igf2 |
CN111349695A (zh) * | 2020-03-30 | 2020-06-30 | 陕西科技大学 | 基于焦磷酸测序技术的gata3基因甲基化检测试剂盒及检测方法 |
CN111235241A (zh) * | 2020-03-30 | 2020-06-05 | 陕西科技大学 | 基于焦磷酸测序技术的foxa1基因甲基化检测试剂盒及检测方法 |
WO2022000399A1 (fr) * | 2020-07-02 | 2022-01-06 | The Johns Hopkins University | Marqueurs méthylés pour la détection précise du lymphome primitif du système nerveux central et du lymphome diffus à grandes cellules b généralisé |
WO2022123419A1 (fr) * | 2020-12-08 | 2022-06-16 | Pfizer Inc. | Traitement de sous-types luminaux de cancer du sein précoce hr-positif, her2-négatif par le palbociclib |
CN114480652A (zh) * | 2022-02-21 | 2022-05-13 | 深圳市陆为生物技术有限公司 | 评价乳腺癌患者对于辅助内分泌治疗的响应性的产品 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003000189A2 (fr) * | 2001-06-21 | 2003-01-03 | Baylor College Of Medicine | Voie de p38 mapk de prevision de la croissance d'un cancer du sein resistant a l'endocrine et de generation d'un nouveau diagnostic et traitement cible |
WO2006004597A2 (fr) * | 2004-06-01 | 2006-01-12 | University Of Southern California | Association de profils de methylation d'adn du cancer du sein avec un etat de recepteur hormonal et reponse au tamoxifene |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012098215A1 (fr) * | 2011-01-20 | 2012-07-26 | Université Libre de Bruxelles | Profils épigénétiques des cancers du sein humains |
-
2016
- 2016-07-14 WO PCT/AU2016/050615 patent/WO2017008117A1/fr active Application Filing
- 2016-07-14 AU AU2016293381A patent/AU2016293381A1/en not_active Abandoned
- 2016-07-14 CN CN201680051447.9A patent/CN107922977A/zh active Pending
- 2016-07-14 EP EP16823558.8A patent/EP3322823A4/fr not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003000189A2 (fr) * | 2001-06-21 | 2003-01-03 | Baylor College Of Medicine | Voie de p38 mapk de prevision de la croissance d'un cancer du sein resistant a l'endocrine et de generation d'un nouveau diagnostic et traitement cible |
WO2006004597A2 (fr) * | 2004-06-01 | 2006-01-12 | University Of Southern California | Association de profils de methylation d'adn du cancer du sein avec un etat de recepteur hormonal et reponse au tamoxifene |
Non-Patent Citations (6)
Title |
---|
CAROLYN L SMITH ET AL: "Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence", BREAST CANCER RESEARCH AND TREATMENT, KLUWER ACADEMIC PUBLISHERS, BO, vol. 136, no. 1, 27 September 2012 (2012-09-27), pages 253 - 265, XP035125727, ISSN: 1573-7217, DOI: 10.1007/S10549-012-2262-7 * |
K W MERRELL ET AL: "Differential recruitment of nuclear receptor coregulators in ligand-dependent transcriptional repression by estrogen receptor-[alpha]", ONCOGENE, vol. 30, no. 13, 22 November 2010 (2010-11-22), London, pages 1608 - 1614, XP055587477, ISSN: 0950-9232, DOI: 10.1038/onc.2010.528 * |
L. ZHANG ET AL: "SpliceArray Profiling of Breast Cancer Reveals a Novel Variant of NCOR2/SMRT That Is Associated with Tamoxifen Resistance and Control of ER? Transcriptional Activity", CANCER RESEARCH, vol. 73, no. 1, 1 November 2012 (2012-11-01), Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA, pages 246 - 255, XP055367636, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-12-2241 * |
RYO AKIHIDE ET AL: "Pinning down HER2-ER crosstalk in SMRT regulation.", TRENDS IN BIOCHEMICAL SCIENCES APR 2009, vol. 34, no. 4, April 2009 (2009-04-01), pages 162 - 165, XP002791216, ISSN: 0968-0004 * |
See also references of WO2017008117A1 * |
T VAN AGTHOVEN ET AL: "CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer", BRITISH JOURNAL OF CANCER, vol. 101, no. 11, 10 November 2009 (2009-11-10), GB, pages 1824 - 1832, XP055587459, ISSN: 0007-0920, DOI: 10.1038/sj.bjc.6605423 * |
Also Published As
Publication number | Publication date |
---|---|
AU2016293381A1 (en) | 2018-01-25 |
WO2017008117A1 (fr) | 2017-01-19 |
EP3322823A1 (fr) | 2018-05-23 |
CN107922977A (zh) | 2018-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3194624A4 (fr) | Méthodes pour le diagnostic, le pronostic et la surveillance du cancer du sein et réactifs correspondants | |
EP3524689A4 (fr) | Méthode de prédiction du pronostic chez une patiente atteinte du cancer du sein | |
EP3322823A4 (fr) | Procédé de diagnostic, de pronostic et de suivi d'un cancer du sein et réactifs correspondants | |
EP3425055A4 (fr) | Réactif de détection/diagnostic moléculaire concernant une tumeur | |
EP3156498A4 (fr) | Kit ou dispositif de détection du cancer du sein, et procédé de détection du cancer du sein | |
EP3177739A4 (fr) | Biomarqueur à base de microarn utilisable en vue du diagnostic du cancer gastrique | |
EP3359692A4 (fr) | Procédé de classification et de diagnostic du cancer | |
EP3119908A4 (fr) | Détermination de l'agressivité d'un cancer, de son pronostic et de sa sensibilité à un traitement | |
HK1208501A1 (en) | Method for the diagnosis, prognosis and treatment of lung cancer metastasis | |
EP3126814A4 (fr) | Procédés et systèmes pour le diagnostic et le pronostic du cancer | |
EP3622071A4 (fr) | Arn circulant pour la détection, la prédiction et la surveillance du cancer | |
EP2988131A4 (fr) | Marqueur génétique pour la prédiction pronostique et le diagnostic précoces du cancer du sein et leur utilisation | |
EP3230745A4 (fr) | Biomarqueurs d'auto-anticorps dans le plasma pour cancer du sein de type basal | |
EP3180450A4 (fr) | Procédé pour le pronostic du cancer de l'ovaire, stratification du patient | |
EP3298145A4 (fr) | Méthode de diagnostic du cancer du sein | |
EP3149210A4 (fr) | Méthode et systèmes pour le diagnostic du cancer du poumon | |
EP4202441A3 (fr) | Profil d'expression génétique dans les macrophages pour le diagnostic du cancer | |
MA40636A (fr) | Procédés pour détecter le cancer de la prostate | |
EP3430406B8 (fr) | Méthode de diagnostic et de pronostic d'un cancer | |
EP3134545A4 (fr) | Procédé et biomarqueur utilisables en vue de la détection d'un cancer | |
EP3292218A4 (fr) | Compositions et méthodes pour la surveillance, le diagnostic, le pronostic, la détection et le traitement du cancer | |
GB201619808D0 (en) | Biomarkers for the prognosis and diagnosis of cancer | |
EP3415914A4 (fr) | Procédé, biomarqueur et agent de diagnostic pour la détection du cancer de la prostate à haut risque | |
EP3639028A4 (fr) | Méthodes de diagnostic, de pronostic et de surveillance de cancers à tumeur solide | |
EP3702784A4 (fr) | Méthode de diagnostic du cancer à partir du sang |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20180205 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20190522 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12Q 1/48 20060101ALI20190514BHEP Ipc: C12Q 1/68 20180101AFI20190514BHEP Ipc: G01N 33/574 20060101ALI20190514BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20191218 |